{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T03:47:17Z","timestamp":1792381637225,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jaad.2005.03.030","type":"journal-article","created":{"date-parts":[[2005,7,14]],"date-time":"2005-07-14T10:59:21Z","timestamp":1121338761000},"page":"341-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pseudoporphyria induced by voriconazole"],"prefix":"10.1016","volume":"53","author":[{"given":"Misty T.","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.03.030_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mjd.2000.111338","article-title":"Pseudoporphyria","volume":"44","author":"Green","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000251392","article-title":"Uber Porphyria-cutanea tarda-artige hautveranderungen bei Langzeithalodialysepatienten","volume":"150","author":"Korting","year":"1975","journal-title":"Dermatologica"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.03.030_bib3","first-page":"40S","article-title":"Pseudoporphyria and UVA suntan salons","volume":"45","author":"Epstein","year":"1987","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jaad.2005.03.030_bib4","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.296.6638.1708","article-title":"Skin fragility and blistering due to sunbeds","volume":"296","author":"Farr","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2005.03.030_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2133.1989.tb01331.x","article-title":"Sunbed-induced pseudoporphyria","volume":"120","author":"Murphy","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archderm.1989.01670210074010","article-title":"Porphyria-like bullous dermatosis after chronic intense tanning bed and\/or sunlight exposure","volume":"125","author":"Poh-Fitzpatrick","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2340\/0001555570354356","article-title":"Pseudoporphyria and sunbeds","volume":"70","author":"Stenberg","year":"1990","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2005.03.030_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/014107689208500117","article-title":"Identical twins with sunbed-induced pseudoporphyria","volume":"85","author":"Wilson","year":"1992","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2005.03.030_bib9","first-page":"61","article-title":"Solarium pseudoporphyria","volume":"6","author":"Thomsen","year":"1989","journal-title":"Photodermatology"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2005.03.030_bib10","first-page":"S53","article-title":"PUVA-induced acral blisters: histopathological features, differential diagnosis, and clinicopathological correlations","volume":"7","author":"Barroni","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.03.030_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/0003-4819-83-4-480","article-title":"Bullous dermatosis of hemodialysis","volume":"83","author":"Gilchrest","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2005.03.030_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archderm.1993.01680230117017","article-title":"Hyperpigmentation, bullae, and keratotic papules in a renal dialysis patient","volume":"129","author":"Ross","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2133.1976.tb00866.x","article-title":"Bullous dermatosis of chronic renal failure","volume":"95","author":"Keczkes","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/03009749509099294","article-title":"Naproxen-induced pseudoporphyria: appearance of new skin lesions after discontinuation of treatment","volume":"24","author":"Girschick","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/120347549900300314","article-title":"Pseudoporphyria induced by propionic acid derivatives","volume":"3","author":"Al-Khenaizan","year":"1999","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2005.03.030_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(85)91478-3","article-title":"Pseudoporphyria due to naproxen","volume":"1","author":"Howard","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.03.030_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.1780330621","article-title":"Bullous photosensitivity to naproxen: \u201cpseudoporphyria\u201d","volume":"33","author":"Suarez","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2005.03.030_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archderm.1986.01660160107028","article-title":"Naproxen-induced pseudoporphyria: a clinical and ultrastructural study","volume":"122","author":"Judd","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0560.1999.tb01789.x","article-title":"Pseudoporphyria associated with Relafen therapy","volume":"26","author":"Magro","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2005.03.030_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2133.1998.02147.x","article-title":"Pseudoporphyria caused by nabumetone","volume":"138","author":"Varma","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0190-9622(99)70507-4","article-title":"Pseudoporphyria induced by nabumetone","volume":"40","author":"Krischer","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2133.1999.03077.x","article-title":"Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs","volume":"141","author":"Meggitt","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib23","first-page":"2703","article-title":"Two cases of nabumetone-induced pseudoporphyria","volume":"26","author":"Checketts","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2133.2000.03516.x","article-title":"Nabumetone-associated pseudoporphyria","volume":"142","author":"Antony","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archderm.1996.03890360113027","article-title":"Oxaprozin-induced pseudoporphyria","volume":"132","author":"Ingrish","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib26","first-page":"322","article-title":"Pseudoporphyria from nonsteroidal anti-inflammatory drugs","volume":"100","author":"Taylor","year":"1987","journal-title":"NZ Med J"},{"key":"10.1016\/j.jaad.2005.03.030_bib27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1365-2133.1998.2576p.x","article-title":"Pseudoporphyria induced by mefenamic acide","volume":"139","author":"O'Hagan","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib28","first-page":"2938","article-title":"Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis","volume":"27","author":"Cummins","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaad.2003.04.003","article-title":"Rofecoxib-induced pseudoporphyria","volume":"50","author":"Markus","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib30","first-page":"445","article-title":"Bullous photodermatitis following nalidixic acid","volume":"24","author":"Louis","year":"1973","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2005.03.030_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.1969.tb13994.x","article-title":"Phototoxic bullous eruptions due to nalidixic acid","volume":"81","author":"Birkett","year":"1969","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.1990.tb01464.x","article-title":"Sunbed pseudoporphyria induced by nalidixic acid","volume":"123","author":"Bilsland","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archderm.1976.01630290011002","article-title":"Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization","volume":"112","author":"Epstein","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib34","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.jaad.2003.08.023","article-title":"\u03b2-Lactam antibiotic-induced pseudoporphyria","volume":"51","author":"Phung","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0190-9622(89)80381-0","article-title":"Chlorthalidone-induced pseudoporphyria: clinical and microscopic findings of a case","volume":"21","author":"Baker","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0190-9622(08)81209-1","article-title":"Bumetanide-induced pseudoporphyria","volume":"23","author":"Leitao","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000018012","article-title":"Pseudoporphyria cutanea tarda induced by furosemide in a patient undergoing peritoneal dialysis","volume":"197","author":"Breier","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2005.03.030_bib38","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bmj.300.6737.1468-a","article-title":"Pseudoporphyria due to Dyazide in a patient with vitiligo","volume":"300","author":"Motley","year":"1990","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2005.03.030_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2230.1993.tb00974.x","article-title":"Isotretinoin-associated pseudoporphyria","volume":"18","author":"Riordan","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2230.1989.tb02606.x","article-title":"Pseudoporphyria complicating etretinate therapy","volume":"14","author":"McDonagh","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(09)80011-X","article-title":"Pseudoporphyria in a patient receiving carisoprodol\/aspirin therapy","volume":"31","author":"Hazen","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib42","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00007890-198705000-00042","article-title":"Pseudoporphyria cutanea tarda associated with cyclosporine therapy","volume":"43","author":"Sola","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.03.030_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1445-5994.1992.tb02154.x","article-title":"5-Fluorouracil-induced pseudoporphyria","volume":"22","author":"Laidman","year":"1992","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.jaad.2005.03.030_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(84)80115-2","article-title":"Cutaneous skin changes probably due to pyridoxine abuse","volume":"10","author":"Baer","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib45","first-page":"146","article-title":"Amiodarone-induced pseudo-porphyria","volume":"5","author":"Parodi","year":"1988","journal-title":"Photodermatology"},{"key":"10.1016\/j.jaad.2005.03.030_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2133.1998.02197.x","article-title":"Flutamide-induced pseudoporphyria","volume":"138","author":"Borroni","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-4362.1991.tb03503.x","article-title":"Pseudoporphyria due to Cola","volume":"30","author":"Judd","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archderm.139.2.227","article-title":"Pseudoporphyria induced by oral contraceptive pills","volume":"139","author":"Silver","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4065\/76.5.488","article-title":"Pseudoporphyria: a clinical and biochemical study of 20 patients","volume":"76","author":"Schanbacher","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2005.03.030_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archderm.1986.01660160059018","article-title":"Porphyria, pseudoporphyria, pseudopseudoporphyria\u2026?","volume":"122","author":"Poh-Fitzpatrick","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200203020-00001","article-title":"Six novel antimycotics","volume":"3","author":"Rubin","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.jaad.2005.03.030_bib53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2230.2001.00909.x","article-title":"Muco-cutaneous retinoid effects and facial erythema related to the novel triazole antifungal agent voriconazole","volume":"26","author":"Denning","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1523-1747.ep12259992","article-title":"Nalidixic acid-induced photosensitivity in mice: a model for pseudoporphyria","volume":"82","author":"Keane","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.03.030_bib55","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(85)92476-6","article-title":"Pseudoporphyria due to naproxen","volume":"1","author":"Farr","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.03.030_bib56","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-2952(99)00154-9","article-title":"Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria","volume":"58","author":"Lambrecht","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaad.2005.03.030_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1185\/030079903125001884","article-title":"Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole","volume":"19","author":"Ullmann","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2005.03.030_bib58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(24)39255-9","article-title":"Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor","volume":"293","author":"Tang","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2005.03.030_bib59","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1124\/dmd.31.9.1090","article-title":"Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes","volume":"31","author":"Kim","year":"2003","journal-title":"Drug Metabol Dispos"},{"key":"10.1016\/j.jaad.2005.03.030_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002280050731","article-title":"In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin-II receptor antagonists","volume":"56","author":"Taavitsainen","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2005.03.030_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0090-9556(24)15118-5","article-title":"Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A2","volume":"28","author":"Ma","year":"2000","journal-title":"Drug Metabol Dispos"},{"key":"10.1016\/j.jaad.2005.03.030_bib62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2125.2003.01993.x","article-title":"Voriconazole, a novel wide-spectrum triazole; oral pharmacokinetics and safety","volume":"56","author":"Purkins","year":"2003","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205009837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205009837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:39:10Z","timestamp":1759268350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205009837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0190962205009837"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.03.030","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudoporphyria induced by voriconazole","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}